1.Firouzi M.; Haghighijoo Z.; Eskandari M.; Mohabbati M.; Miri R.; Jamei M.H.; Poustforoosh A.; Nazari S.; Firuzi O.; Khoshneviszadeh M.; Edraki N. Synthesis and cytotoxic activity evaluation of novel imidazopyridine carbohydrazide derivatives. BMC Chemistry. Volume 18, Issue 1.December 2024
2.Divar, M.,Edraki, N., Damghani, T., Moosavi, F., Mohabbati, M., Alipour, A., Pirhadi, S., Saso, L., Khabnadideh, S., Firuzi .,O. Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT۳ kinase inhibitors. Bioorganic and Medicinal Chemistry. Volume ۹۰۱۵ July ۲۰۲۳ Article number ۱۱۷۳۶۷
3.A.Iraji., N.Shahrokh., O.Firuzi., M.Mohabbati., R.Miri., H.Sadeghpour., M.Khoshneviszadeh., N.Edraki. Acenaphthotriazine Thio-triazole Derivatives as Anti-cancer Agents Triggering Cell Cycle Arrest in Breast Cancer Cells. Letters in Drug Design and Discovery. Volume ۲۰, Issue ۶, Pages ۶۳۹ - ۶۴۸۲۰۲۳
4.M. Divar., S. Tadayyon., M. Khoshneviszadeh., S.Pirhad., M. Attarroshan., K. Mobaraki., T.Damghani., S.Mirfazli., N. Edraki. Benzyl-Triazole Derivatives of Hydrazinecarbothiamide Derivatives as Potent Tyrosinase Inhibitors: Synthesis, Biological Evaluation, Structure-Activity Relationship and Docking Study. ChemistrySelect. Volume ۸, Issue ۸۲۳ February ۲۰۲۳
5.M.Mortazavi., E.Raufi., T.Damghani., M.Khoshneviszadeh., N.Edraki., M.Eskandari., E.Giovannetti., G.J. Peters., S.Pirhadi., O.Firuzi. Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library. European Journal of Pharmacology. Volume ۹۳۸, ۵ January ۲۰۲۳
6.S.Ranjbar., F.Faramin Lashkarian ., M. Khoshneviszadeh ., F. Moosavi., A. Sakhteman ., F.Zargari ., L.Saso ., O.Firuzi ., N.Edraki. ۵-Oxohexahydroquinolines bearing ۴-pyridyl methyl carboxylate as P-glycoprotein inhibitors and multidrug resistance reversal agents in cancer cells. Journal of Molecular Structure.Volume ۱۲۸۵, ۵ August ۲۰۲۳
7.Attarroshan M.,Firuzi O.,Iraji A.,Sharifi S.,Tavakkoli M.,Vesal M.,Khoshneviszadeh M.,Pirhadi S.,Edraki N. Imino-۲H-Chromene Based Derivatives as Potential Anti-Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study. Chemistry and Biodiversity. ۲۰۲۲
8.Bahreini M.S., Iraji A., Edraki N., Monfared A.A., Asgari Q. Synthesis and anti-Toxoplasma activity of indole-triazole compounds on tachyzoites of RH strain. Annals of Medicine and Surgery. Volume ۷۴ - February ۲۰۲۲
9.Rastegari, A., Safavi, M., Vafadarnejad, F., Najafi, Z., Hariri, R., Bukhari, S.N.A., Iraji, A., Edraki, N., Firuzi, O., Saeedi, M., Mahdavi, M., Akbarzadeh, T. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer’s disease. Molecular Diversity. Volume ۲۶, Issue ۱, Pages ۴۰۹ - ۴۲۸
10.Ranjbar S., Khoshneviszadeh M., Tavakkoli M. , Miri R., Edraki N., Firuzi O. ۵-Oxo-hexahydroquinoline and ۵-oxo-tetrahydrocyclopentapyridine derivatives as promising antiproliferative agents with potential apoptosis-inducing capacity.Molecular Diversity. ۲۰۲۲/۶
11.M Firouzi, Z Haghighijoo, M Eskandari, M Mohabbati, R Miri, MH Jamei,O Firuzi, M Khoshneviszadeh, N Edraki. Synthesis and Cytotoxic Activity Evaluation of Novel Imidazopyridine Carbohydrazide Derivatives. ۲۰۲۲
12.SE. Ebrahimi., A.Iraji., K.Jelveh., A.Moazzam., S.Bahadorikhalili., A. Yahya‐Meymandi., B.Larijani., M. Biglar., N.Edraki., M. Mahdavi*. Aminoimidazo[۱,۲-a]pyridine Bearing Different Pyrazole Moieties as the Structural Scaffold for the Development of BACE۱ Inhibitor; Synthesis, Structural Characterization, in vitro and in silico Studies.Current Organic Synthesis. Volume ۱۹, Issue ۶, ۲۰۲۲
13.Sh.Mahernia., M.Hassanzadeh., M.Adib., F.Peytam., Z.Haghighijoo., A.Iraji, M.Mahdavi, N.Edraki, M. Amanlou.The possible effect of microRNA-۱۵۵ (miR-۱۵۵) and BACE۱ inhibitors in the memory of patients with down syndrome and Alzheimer's disease: Design, synthesis, virtual screening, molecular modeling and biological evaluations. Journal of Biomolecular Structure and Dynamics . ۲۰۲۲ Aug;۴۰(۱۳):۵۸۰۳-۵۸۱۴.
14.S.Karimian, M.Shekouhy, S.Pirhadi, A.Iraji, M.Attarroshan, N.Edraki, M.Khoshneviszadeh. Synthesis and biological evaluation of benzimidazoles/۱, ۳, ۵-triazine-۲, ۴-diamine hybrid compounds: a new class of multifunctional alzheimer targeting agents. New Journal of Chemistry. Issue ۳۲, ۲۰۲۲
15.M.Mortazavi, M. Divar, T. Damghani, F.Moosavi, L.Saso, S.Pirhadi, M.Khoshneviszadeh, N.Edraki, O.Firuzi. Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors. Frontiers in Chemistry. ۲۰۲۲
16.Damghani T., Moosavi F., Khoshneviszadeh M., Mortazavi M., Pirhadi S., Kayani Z., Saso L., Edraki N., Firuzi O. Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met. Scientific Reports. Volume ۱۱, Issue ۱, December ۲۰۲۱, Article number ۳۶۴۴.
17.Saeedi M., Maleki A., Iraji A., Hariri R., Akbarzadeh T., Edraki N., Firuzi O., Mirfazli S.S. Synthesis and bio-evaluation of new multifunctional methylindolinone-۱,۲,۳-triazole hybrids as anti-Alzheimer's agents. Journal of Molecular Structure. Journal of Molecular Structure.
18.Saeedi M., Felegari P., Iraji A., Hariri R., Rastegari A., Mirfazli S.S., Edraki N., Firuzi O., Mahdavi M., Akbarzadeh T. Novel N-benzylpiperidine derivatives of ۵-arylisoxazole-۳-carboxamides as anti-Alzheimer's agents. Archiv der Pharmazie. Volume ۳۵۴, Issue ۳, March ۲۰۲۱, Article number ۲۰۰۰۲۵۸
19.Bozorgi M., Najafi Z., Omidpanah S., Sadri A., Narimani Z., Moghadam F.H., Edraki N., Akbarzadeh T., Saeedi M.Investigation of anti-alzheimer’s activity of aqueous extract of areca nuts (Areca catechu l.): In vitro and in vivo studies [Investigación de la actividad anti-alzheimer del extracto acuoso de nueces de areca (Areca catechu l.): Estudios in vitro e in vivo].Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas.Volume ۲۰, Issue ۴, ۲۰۲۱, Pages ۴۰۶-۴۱۵
20.Mahernia S., Hassanzadeh M., Adib M., Peytam F., Haghighijoo Z., Iraji A., Mahdavi M., Edraki N., Amanlou M.The possible effect of microRNA-۱۵۵ (miR-۱۵۵) and BACE۱ inhibitors in the memory of patients with down syndrome and Alzheimer's disease: Design, synthesis, virtual screening, molecular modeling and biological evaluations.Journal of Biomolecular Structure and Dynamics.۲۰۲۱
21.Maleki M.F., Nadri H., Kianfar M., Edraki N., Eisvand F., Ghodsi R., Mohajeri S.A., Hadizadeh F. Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies. Bioorganic Chemistry. Volume ۱۰۹, April ۲۰۲۱, Article number ۱۰۴۶۸۴.
22. Iraji A., Panahi Z., Edraki N., Khoshneviszadeh M., Design, synthesis, in vitro and in silico studies of novel Schiff base derivatives of ۲-hydroxy-۴-methoxybenzamide as tyrosinase inhibitors.Drug Development Research.Volume ۸۲, Issue ۴, Pages ۵۳۳ - ۵۴۲June ۲۰۲۱.
23. Ranjbar S, Firuzi o, Edraki N, Shahraki O, Khoshneviszadeh M, Miri R. Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis. MedChemComm. ۲۰۱۷; ۸: ۱۹۱۹-۱۹۳۳.
24.Rezai Z, Moghimi s, Javaheri R, Asadi M, Mahdavi M, Shabani S, Edraki N, Firuzi O, safavi M, Amini M, Asadpur A, Firoozpur L, Foroumadi A. Synthesis and biological evaluation of ۱,۳,۴-thiadiazole linked to phthalimide derivatives as anticancer agents.
Letter in Drug Design and Descovery. ۲۰۱۷, ۱۴; ۱۱۳۸-۱۱۴۴.
25. Iraji A, FIruzi O, Khoshneviszadeh M, Tavakkoli M, Mahdavi M, Nadri H, Edraki N*, Miri R. Multifunctional iminochromene-۲H-carboxamide derivatives containing different aminomethylene triazole with BACE۱ inhibition, neuroprotective and metal chelatingEuropean
Journal of Medicinal Chemistry. ۲۰۱۷. In press. (*Corresponding author).
26. Menezes J.C.M S, Edraki N, Kamat S.P, Khoshneviszadeh M., Kayani Z, Hadavand Mirzaei H, Miri R, Erfani N, Nejati M, Cavaleiro J.A.S., Silva T, Saso L, Borges F, Firuzi O, Long Chain Alkyl Esters of Hydroxycinnamic Acids as Promising Anticancer Agents: Selective Induction of Apoptosis in Cancer Cells. Journal of Agricultural and food chemistry. ۲۰۱۷. ۶۵ (۳۳): ۷۲۲۸-۷۲۳۹.
27. Haghighijoo Z, Firuzi O, Hemmateenejad B, Emami S, Edraki N*, Miri R. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer’s disease. European journal of medicinal chemistry. ۲۰۱۷. ۷۴: ۱۲۶-۱۳۳
(*Corresponding author).
28. Sakhteman AH, Edraki N , Hemmateenejad B, Miri R , Foroumadi A, Shafiee A, Khoshneviszadeh M. In Silico Screening of IL-۱β Production Inhibitors Using Chemometric Tools. Iranian Journal of Pharmaceutical Research. ۲۰۱۷;۱۶ (۲): ۵۱۳-۵۲۴.
29. Haghighijoo Z, Hemmateenejad B, Edraki N, Miri R, Emami S. Multi-structure docking analysis of BACE۱ crystal structures and non-peptidic ligands. J Mol Mod graph. ۲۰۱۷; ۷۶-۱۲۸-۱۳۵.
30. Azimi S , Zonouzi F , Firuzi O , Aida Iraji A , Saeedi M , Mahdavi M , Edraki N*. Discovery of Imidazopyridines Containing Isoindoline-۱,۳-dione Framework as a New Class of BACE۱ Inhibitors: Design, Synthesis and SAR Analysis.
European Journal of Medicinal Chemistry. ۲۰۱۷, ۲۴: ۷۲۹-۷۳۷.(*Corresponding author)
31. Sameem, B, Saeedi, M, Mahdavi, M, Nadri, H, Moghadam, FH, Edraki N, Khan, MI., Amini, M. Synthesis, docking study and neuroprotective effects of some novel pyrano[۳,۲-c]chromene derivatives bearing morpholine/phenylpiperazine moiety.Bioorg Med Chem. ۲۰۱۷; ۲۵: ۳۹۸۰-۳۹۸۸.
32. Shahraki O, Zargari F, Edraki N*, Khoshneviszadeh M, Firuzi O, Miri R. Molecular dynamics simulation and moleculardocking studies of ۱,۴-Dihydropyridines as Pglycoprotein’s allosteric inhibitors. Journal of Biomolecular Structure and Dynamics. ۲۰۱۷. (*Corresponding author)
33. Moosavi F, Hosseini R , Rajaian H Silva T , Silva DM Saso L, Edraki N, Miri R , Borges F , Firuzi O. Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents.Bioorganic and Medicinal Chemistry. ۲۰۱۷; ۲۵: ۳۲۳۵-۳۲۴۶.
34. Shahraki O, Edraki N, Khoshneviszadeh M, Zargari F, Ranjbar S, Saso L, Firuzi O, Miri R. Novel ۵-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study.
Drug Design, Development and Therapy. ۲۰۱۷; ۱۱: ۴۰۷-۴۱۸.
35.Saeedi M , Safavi M , Karimpour-Razkenari E , Mahdavi M , Edraki N , Homayouni Moghadam F , Khanavi M , Akbarzadeh T, Synthesis of novel chromenones linked to ۱,۲,۳-triazole ring system: Investigation of biological activities against Alzheimer's disease", Bioorganic Chemistry. ۲۰۱۷, ۷۰: ۸۶-۹۳.
36. Hariri R, Afshar Z, Mahdavi M, Safavi M, Saeedi M, Najafi Z, Sabourian R, Karimpour-Razkenari E, Edraki N, Homayouni F, Shafiee A, Khanavi M, Akbarzadeh, Novel Tacrine-Based Pyrano[۳’,۴’:۵,۶]pyrano[۲,۳-b]quinolinones: Synthesis and Cholinesterase Inhibitory Activity. Arch. Pharm. Chem. Life Sci. (Weinheim). ۲۰۱۶, ۳۴۹,۹۱۵-۹۲۴.
37. Hosseini R, Moosavi F, Rajaian H, Silva T, Silva DM, Soares P, Saso L, Edraki N, Miri R, Borges F, Firuzi O. Discovery of neurotrophic agents based on hydroxycinnamic acid scaffold. Chem Biol Drug Des. ۲۰۱۶; .۸۸: ۹۲۶-۹۳۸.
38. Edraki N, Iraji A, Firuzi O, Fattahi Y, Mahdavi M, Foroumadi AR, Khoshneviszadeh M, Shafiee A, Miri R. ۲‑Imino ۲H‑chromene and ۲‑(phenylimino) ۲H‑chromene ۳‑aryl carboxamide derivatives as novel cytotoxic agents: synthesis, biological assay, and molecular docking study. Journal of the Iranian Chemical Society ۲۰۱۶; ۱۳: ۲۱۶۳-۲۱۷۱.
39. S Malhotra S, Tavakkoli M, Edraki N, Mir Ri, Sharma SK, Prasad AK, Saso L, Len C, Parmar VS, Firuzi O, Neuroprotective and Antioxidant Activities of ۴-Methylcoumarins: Development of Structure–Activity Relationships Biol. Pharm. Bull.۲۰۱۶, ۳۹, ۱۱۵۴۴-۱۵۴۸.
40. Najafi Z, Saeedi M, Mahdavi M, Sabourian R, Khanavi M, Barazandeh Tehrani M, Homayouni Moghadam F, Edraki N, Karimpor-Razkenari E, Sharifzadeh M, Foroumadi F, Shafiee A, Akbarzadeh T. Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids. Bioorganic Chemistry. ۲۰۱۶; ۶۷, ۸۴–۹۴.
41. Edraki N, Das U, Hemmateenejad B, DimmocK JR, Miri R. Comparative QSAR analysis of ۳,۵-bis (arylidene)-۴-piperidone derivatives: The development of predictive cytotoxicity models. Iranian Journal of Pharmaceutical .Research. ۲۰۱۶;۱۵, ۴۲۵-۴۳۷.
42. Khoshneviszadeh M, Shahraki O, Khoshneviszadeh M, Foroumadi A, Firuzi O, Edraki N, Nadri H, Moradi A, Shafiee A, Miri R. Structure-based design, synthesis, molecular docking study and biological evaluation of ۱,۲,۴-triazine derivatives acting as COX/۱۵-LOX inhibitors with anti-oxidant activities. J Enzyme Inhib Med Chem , ۲۰۱۶; ۳۰, ۱-۱۰.
43. Almasirad, A ; Firoozpour, L ; Nejati, M ; Edraki, N ; Firuzi, O ; Khoshneviszadeh, M ; Mahdavi, M ; Moghimi, S ; Safavi, M ; Shafiee, A ; Foroumadi, A. Design, synthesis, and biological evaluation of new series of ۲-amido-۱,۳,۴-thiadiazole derivatives as cytotoxic agents. Zeitschrift Fur Naturforschung, Section B, Journal of chemical sciences.. ۲۰۱۶ ۷۱, ۲۰۵-۲۱۰.
44. Mohammadhosseini N, Pordelib M, Safavi M , Firoozpourd L, Amine F, Kabudanian Ardestanib S, Edraki N, Shafiee A, Alireza Foroumadid A. Novel N-۲-(Furyl)-۲-(chlorobenzyloxyimino) ethyl Piperazinyl Quinolones: Synthesis, Cytotoxic Evaluation and Structure-activity Relationship., Iranian Journal of Pharmaceutical Research (۲۰۱۵), ۱۴ (۴): ۱۰۹۵-۱۱۰۳.
45. Silva T, Borges B, Edraki N, Alizadeh M, Miri R, Saso L, Firuz O. Hydroxycinnamic acid as a novel scaffold for the development of cyclooxygenase-۲ inhibitors. RSC Adv., ۲۰۱۵, ۵, ۵۸۹۰۲-۱۱.
46. Alvandifar F, Tahghighi A, Sabourian R, Firoozpour L, Mahdavi M, Saniee P, Edraki N, Moshafi M, Shafiee A, Foroumadi A. ۲-Substituted-۵-(۵-nitro-furan-۲-yl)-۱,۳,۴-thiadiazoles:Anti-Helicobacter pylori activity evaluation and docking study, Journal of Chemical and Pharmaceutical Research. ۲۰۱۵, ۷(۳): ۲۵۱۲-۲۵۱۹.
47. Edraki N, Firuzi O, Fatahi Y, Mahdavi M, Asadi M, Emami S, Divsalar K, Miri R, Iraji A, Khoshneviszadeh M, Firoozpour L, Shafiee A, Foroumadi A. N-(۲-(Piperazin-۱-yl)phenyl)arylamide Derivatives as β-Secretase (BACE۱) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation. Arch Pharm (Weinheim). ۲۰۱۵, ۳۴۸, ۱-۸.
48. Akbarzadeh T۱, Noushini S, Taban S, Mahdavi M, Khoshneviszadeh M, Saeedi M, Emami S, Eghtedari M, Sarrafi Y, Khoshneviszadeh M, Safavi M, Divsalar K,Moshafi MH, Asadipour A, Sabourian R, Edraki N, Firouzi O, Miri R, Shafiee A, Foroumadi A. Synthesis and cytotoxic activity of novel poly-substituted imidazo[۲,۱-[Formula: see text]][۱,۲,۴]triazin-۶-amines. Mol Divers. ۲۰۱۵ May; ۱۹(۲):۲۷۳-۸۱.
49. Vosooghi M, Sabourian R , Tahghighi A , Mahdavi M , Emami S, Razmi S, Kabudanian Ardestani S, Safavi M, Foroumadi P, Kaveh S, Khoshneviszadeh M, Edraki N, Shafiee A, Foroumadi A. Synthesis, antileishmanial activity and QSAR study of (۱,۳,۴- thiadiazol-۲-ylthio) acetamides derived from ۵-nitrofuran. Med Chem Res (۲۰۱۵) ۲۴:۸۹۱–۹۰۰.
50. Esmati N, Foroughian M, Saeedi M, Mahdavi M, Khoshneviszadeh M, Firuzi O, Tanideh N, Miri R, Edraki N, Shafiee A, Foroumadi A. Synthesis and Cytotoxic Activity of Some Novel Dihyrobenzo[h]pyrano[۳,۲-c]chromene Derivatives. J. Het. Chem. ۲۰۱۵, ۵۲: ۹۷-۱۰۴.
51. Miri R, Firuzi O, Razzaghi-Asl N, Javidnia K, Edraki N. Inhibitors of Alzheimer's BACE-۱ with ۳,۵-bis-N-(aryl/heteroaryl) carbamoyl-۴-aryl-۱,۴-dihydropyridine structure. Arch Pharm Res. ۲۰۱۴ Apr ۲۶, ۳۸ (۴), ۴۵۶-۶۹.
52. Motamedi R, Shafiee A, Rezai MR, Firuzi O, Edraki N, Miri R. Oxidative Aromatization, Cytotoxic Activity Evaluation and Conformational Study of Novel ۷-aryl-۱۰, ۱۱-dihydro-۷H-chromeno [۴, ۳-b]quinoline-۶, ۸(۹H, ۱۲H)-dione Derivatives. Iraninan Journal of Pharmaceutical Research. ۲۰۱۴, ۱۳: ۱۰۳-۱۱۴.
53. Edraki N, Firuzi O, Foroumadi A, Miri R, Madadkar-Sobhani A, Khoshneviszadeh M, Shafiee A. Phenylimino-۲H-chromen-۳-carboxamide derivatives as novel small molecule inhibitors of b-secretase (BACE۱). Bioorganic & Medicinal Chemistry ۲۱ (۲۰۱۳) ۲۳۹۶–۲۴۱۲.
54. Shahrisa A, Esmati S, Miri R, Firuzi O, Edraki N, Nejati M. Cytotoxic activity assessment, QSAR and docking study of novel bis-carboxamide derivatives of ۴-pyrones synthesized by Ugi four-component reaction, European Journal of Medicinal Chemistry, ۶۶ (۲۰۱۳) ۳۸۸-۳۹۹.
55. Khoshnevisazadeh M, Ghahremani M.H, Foroumadi A, Miri R, Firuzi O, Madadkar-Sobhani A, Edraki N, Parsa M, Shafiee A. Design, synthesis and biological evaluation of novel anti-cytokine ۱,۲,۴-triazine derivatives Original Research Article Bioorganic & Medicinal Chemistry, ۲۱ (۲۰۱۳) ۶۷۰۸-۶۷۱۷.
56. Razzaghi-Asl N, Firuzi O, Hemmateenejad B, Javidnia K, Edraki N, Miri R. Design and synthesis of novel ۳,۵-bis-N-(aryl/heteroaryl) carbamoyl-۴-aryl-۱,۴-dihydropyridines as small molecule BACE-۱ inhibitors. Bioorganic & Medicinal Chemistry. (۲۰۱۳) ۱۵; ۲۱(۲۲):۶۸۹۳-۹۰۹.
57. Mohammadhosseini N, Saniee P, Ghamari Pour A, Aryapour H, Afshar F, Edraki N, Siavoshi F, Foroumadi A, Shafiee A. Synthesis and biological evaluation of novel benzyl piperazine derivatives of ۵-(۵-nitroaryl)-۱,۳,۴-thiadiazoles as Anti-Helicobacter pylori agents. DARU journal of pharmaceutiocal sciences. (۲۰۱۳) ۸; ۲۱(۱):۶۶-۷۳.
58. Asadipour A, Edraki N, Nakhjiri M, Yahya-Meymandi A, Alipour A, Sanieee P, Siavoshi F, Shafiee A, Foroumadi A. Anti-Helicobacter pylori activity and Structure-Activity Relationship study of ۲-Alkylthio-۵-(nitroaryl)-۱,۳,۴-thiadiazole Derivatives. Iranian Journal of Pharmaceutical Research (۲۰۱۳), ۱۲ (۳): ۲۸۱-۲۸۷.
59. Sarkarzadeh H, Miri R, Firuzi O, Amini M, Nima Razzaghi-Asl N, Edraki N, Shafiee A. Synthesis and antiproliferative activity evaluation of imidazole-based indeno[۱,۲-b]quinoline-۹,۱۱-dione derivatives. Arch. Pharm. Res. (۲۰۱۳) ۳۶ (۴): ۴۳۶–۴۴۷. [۲۰۱۳ Apr;۳۶(۴):۴۳۶-۴۷. doi: ۱۰.۱۰۰۷/s۱۲۲۷۲-۰۱۳-۰۰۳۲-۷. Epub ۲۰۱۳ Feb ۲۶.].
60. Vosooghi M, Yahyavi H, Divsalar K, Shamsa H, Kheirollahi A, Safavi M, Ardestani SK, Sadeghi-Neshat S, Mohammadhosseini N, Edraki N, Khoshneviszadeh M, Shafiee A, Foroumadi A Synthesis and In vitro cytotoxic activity evaluation of (E)-۱۶-(substituted benzylidene) derivatives of dehydroepiandrosterone.DARU Journal of Pharmaceutical Sciences (۲۰۱۳), ۲۱:۳۴-۴۰ [۲۰۱۳ May ۱;۲۱(۱):۳۴. doi: ۱۰.۱۱۸۶/۲۰۰۸-۲۲۳۱-۲۱-۳۴].
61. Razzaghi-Asl N, Ebadi A, Edraki N, Shahabipour S, Miri R. Fragment-based Binding Efficiency Indices in Bioactive Molecular Design: A Computational Approach to BACE-۱ Inhibitors. Iranian Journal of Pharmaceutical Research (۲۰۱۳), ۱۲ (۳): ۴۲۳-۴۳۶. [۲۰۱۳ Summer;۱۲(۳):۴۲۳-۳۶.].
62. Firoozpour L, Edraki N, Nakhjiri M, Emami S, Safavi M, Kabudanian Ardestani S, Khoshneviszadeh M, Shafiee A. Foroumadi A. Cytotoxic Activity Evaluation and QSAR Study of Chromene-based Chalcones. Arch Pharm Res (۲۰۱۲) Vol ۳۵, No ۱۲, ۲۱۱۷-۲۱۲۵, ۲۰۱۲.[ ۲۰۱۲ Dec;۳۵(۱۲):۲۱۱۷-۲۵. doi: ۱۰.۱۰۰۷/s۱۲۲۷۲-۰۱۲-۱۲۰۸-۲. Epub ۲۰۱۲ Dec ۲۱.]
63. Razzaghi-Asl N, Ebadi A, Edraki N, Mehdipour A, Shahabipour S, Miri R. Response surface methodology in docking study of small molecule BACE-۱ inhibitors. J Mol Model.( ۲۰۱۲ ) ۱۸(۱۰): ۴۵۶۷-۷۶. [ ۲۰۱۲ Oct;۱۸(۱۰):۴۵۶۷-۷۶. doi: ۱۰.۱۰۰۷/s۰۰۸۹۴-۰۱۲-۱۴۲۴-۱. Epub ۲۰۱۲ May ۱۳]
64. Razzaghi-Asl N, Ebadi A, Edraki N, Shahabipour S, Miri R. Ab initio modeling of a potent isophthalamide-based BACE-۱ inhibitor: amino acid decomposition analysis Med Chem Res. (۲۰۱۲) ۲۲: ۳۲۵۹-۳۲۶۹.
65. Khoshneviszadeh M, Edraki N, Miri R, Foroumadi A, Hemmateenejad B.QSAR Study of ۴-Aryl-۴-H-Chromenes as a New Series of Apoptosis Inducers Using Different Chemometric Tools. Chem Biol Drug Des. ۲۰۱۲ Apr;۷۹(۴):۴۴۲-۵۸.
66. Edraki N, Mehdipour AR, Khoshneviszadeh M, Miri R. Dihydropyridines: evaluation of their current and future pharmacological applications. Drug Discov Today. ۲۰۰۹ Nov;۱۴(۲۱-۲۲):۱۰۵۸-۶۶
67. Khoshneviszadeh M, Edraki N, Javidnia K, Alborzi A, Pourabbas B, Mardaneh J, Miri R. Synthesis and biological evaluation of some new ۱,۴-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents. Bioorg Med Chem. ۲۰۰۹ Feb ۱۵;۱۷(۴):۱۵۷۹-۸۶.
68. Khoshneviszadeh M, Edraki N, Miri R, Hemmateenejad B. Exploring QSAR for substituted ۲-sulfonyl-phenyl-indol derivatives as potent and selective COX-۲ inhibitors using different chemometrics tools. Chem Biol Drug Des. ۲۰۰۸ Dec;۷۲(۶):۵۶۴-۷۴.
69. Miri R., Javidnia K., Mirkhani H., Kazemi F., Hemmateenejad B., Edraki N., Mehdipour A.R. Synthesis and in vitro dual calcium channel antagonist-agonist activity of some ۱, ۴-Dihydo-۲,۶-dimethyl-۳-nitro and cyano-۴-(۱-methyl-۵- nitro-۱H-imidazol-۲-yl)-۵-pyridinecarboxylates. DARU ۲۰۰۸ ۱۶ (۴) ۲۶۳-۲۷۰.
70. Edraki, N., Hemmateenejad, B., Miri R. and Khoshneviszadeh M., QSAR Study of Phenoxypyrimidine Derivatives as Potent Inhibitors of p۳۸ kinase Using different Chemometric Tools. J. Chem. Biol & Drug Design. ۲۰۰۷, Dec. ۷۰-۵۳۰-۵۳۹
71. Miri R., Javidnia K., Mirkhani M., Hemmateenejad B., Sepehr, Z., Zalpour, M., Behzad T., Khoshneviszade M., Edraki N., Mehdipour A., Synthesis QSAR and Calcium Channel Modulator Activity of New Hexahydroquinoline Derivativews Containing Nitroimidazole, J. Chem. Biol & Drug Design. ۲۰۰۷, Oct, ۷۰, ۳۲۹-۳۳۶
72. Hemmateenejad B., Miri R., Edraki N., Khoshneviszadeh M., Shafiee, A., Molecular Modeling and QSAR Analysis of Some ۴,۵-Dichloroimidazolyl-۱,۴-DHP Based Calcium Channel Blockers. JICS .Vol. ۴, No. ۲, June ۲۰۰۷, pp. ۱۸۲-۱۹۳
73. Javidnia K., Miri R., Edraki N. Khoshneviszadeh M., Javidnia A. Constituents of the volatile oil of Ferulago angulata (Schlecht) Boiss. from iran. J. Essent. Oil Res., September/October ۲۰۰۶ ۱۸, ۵۴۸-۵۵۰
74. Hemmateenejad B., Miri R., Safarpour M.A., Edraki N., Khoshneviszadeh M., Conformational analysis of some new derivatives of ۴-nitroimidazolyl-۱,۴-dihydropyridine-based calcium channel blockers. J. Mol. Structure: Theochem, March, ۲۰۰۵, ۷۱۷,۱۳۹-۱۵۲.
75. Javidnia K., Miri R., Kamalinejad M., Edraki N., Chemical composition of Ferula persica Wild. essential oil from Iran. Flavor and Fragrance J., ۲۰۰۵, ۲۰; ۶۰۵-۶۰۶.
